In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer's Disease: A 18F-Florzolotau Study

被引:3
|
作者
Ju, Zizhao [1 ,2 ,3 ]
Li, Zhuoyuan [4 ]
Lu, Jiaying [1 ,2 ,3 ]
Jiao, Fangyang [1 ,2 ,3 ]
Lin, Huamei [1 ,2 ,3 ]
Bao, Weiqi [1 ,2 ,3 ]
Li, Ming [1 ,2 ,3 ]
Wu, Ping [1 ,2 ,3 ]
Guan, Yihui [1 ,2 ,3 ]
Zhao, Qianhua [5 ]
Zhang, Huiwei [1 ,2 ,3 ]
Jiang, Jiehui [6 ]
Zuo, Chuantao [1 ,2 ,3 ]
机构
[1] Fudan Univ, Huashan Hosp, PET Ctr, Shanghai 200035, Peoples R China
[2] Fudan Univ, Huashan Hosp, Natl Res Ctr Aging & Med, Shanghai 200035, Peoples R China
[3] Fudan Univ, Huashan Hosp, Natl Ctr Neurol Disorders, Shanghai 200035, Peoples R China
[4] Shanghai Univ, Sch Commun & Informat Engn, Shanghai 200444, Peoples R China
[5] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200040, Peoples R China
[6] Shanghai Univ, Sch Life Sci, Inst Biomed Engn, Shanghai 200444, Peoples R China
基金
中国国家自然科学基金;
关键词
Florzolotau PET; functional connectivity; mild cognitive impairment; Alzheimer's disease; MILD COGNITIVE IMPAIRMENT; EIGENVECTOR CENTRALITY; GLUCOSE-METABOLISM; HUBS; NETWORKS; CONNECTOME; BIOMARKERS; PET;
D O I
10.3390/brainsci12101355
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Purpose: F-18-Florzolotau is a novel second-generation tau radiotracer that shows higher binding affinity and selectivity and no off-target binding. The proportion loss of functional connectivity strength (PLFCS) is a new indicator for representing brain functional connectivity (FC) alteration. This study aims to estimate the relationship between the regional tau accumulation and brain FC abnormality in Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients based on Florzolotau PET and fMRI. Methods: 22 NC (normal control), 31 MCI and 42 AD patients who have already been scanned with F-18-Florzolotau PET were recruited in this study. (We calculated the PLFCS and standardized uptake value ratio (SUVR) of each node based on the Brainnetome atlas (BNA) template. The SUVR of 246 brain regions was calculated with the cerebellum as the reference region. Further functional connection strength (FCs), PLFCS and SUVR of each brain region were obtained in three groups for comparison.) For each patient, PLFCS and standardized uptake value ratio (SUVR) were calculated based on the Brainnetome atlas (BNA) template. These results, as well as functional connection strength (FCs), were then compared between different groups. Multiple permutation tests were used to determine the target nodes between NC and cognitive impairment (CI) groups (MCI and AD). The relationship between PLFCS and neuropsychological scores or cortical tau deposit was investigated via Pearson correlation analysis. Results: Higher PLFCS and FCs in AD and MCI groups were found compared to the NC group. The PLFCS of 129 brain regions were found to be different between NC and CI groups, and 8 of them were correlated with tau SUVR, including superior parietal lobule (MCI: r = 0.4360, p = 0.0260, AD: r = -0.3663, p = 0.0280), middle frontal gyrus (AD: MFG_R_7_2: r = 0.4106, p = 0.0129; MFG_R_7_5: r = 0.4239, p = 0.0100), inferior frontal gyrus (AD: IFG_R_6_2: r = 0.3589, p = 0.0316), precentral gyrus (AD: PrG_R_6_6: r = 0.3493, p = 0.0368), insular gyrus (AD: INS_R_6_3: r = 0.3496, p = 0.0366) and lateral occipital cortex (AD: LOcC_L_4_3: r = -0.3433, p = 0.0404). Noteworthily, the opposing relationship was found in the superior parietal lobule in the MCI and AD groups. Conclusions: Brain functional connectivity abnormality is correlated with tau pathology in AD and MCI.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Brain Structural and Functional Connectivity and the Progression of Neuropathology in Alzheimer's Disease
    Matthews, Paul M.
    Filippini, Nicola
    Douaud, Gwenaelle
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 : S163 - S172
  • [42] Sex difference in brain functional connectivity of hippocampus in Alzheimer's disease
    Williamson, Jordan
    James, Shirley A.
    Mukli, Peter
    Yabluchanskiy, Andriy
    Wu, Dee H.
    Sonntag, William
    Yang, Yuan
    GEROSCIENCE, 2024, 46 (01) : 563 - 572
  • [43] Brain functional connectivity in response to donepezil treatment in Alzheimer's disease
    Zaidel, L.
    Fields, J.
    Cullum, C.
    Briggs, R.
    Hynan, L.
    Weiner, M. F.
    McColl, R.
    McDonald, E.
    Rubin, C. D.
    Allen, G.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2006, 21 (06) : 588 - 588
  • [44] Sex difference in brain functional connectivity of hippocampus in Alzheimer’s disease
    Jordan Williamson
    Shirley A. James
    Peter Mukli
    Andriy Yabluchanskiy
    Dee H. Wu
    William Sonntag
    Yuan Yang
    GeroScience, 2024, 46 (1) : 563 - 572
  • [45] Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [18F]flortaucipir study
    O'Connor, Antoinette
    Cash, David M.
    Poole, Teresa
    Markiewicz, Pawel J.
    Fraser, Maggie R.
    Malone, Ian B.
    Jiao, Jieqing
    Weston, Philip S. J.
    Flores, Shaney
    Hornbeck, Russ
    McDade, Eric
    Schoell, Michael
    Gordon, Brian A.
    Bateman, Randall J.
    Benzinger, Tammie L. S.
    Fox, Nick C.
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [46] Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study
    Antoinette O’Connor
    David M. Cash
    Teresa Poole
    Pawel J. Markiewicz
    Maggie R. Fraser
    Ian B. Malone
    Jieqing Jiao
    Philip S. J. Weston
    Shaney Flores
    Russ Hornbeck
    Eric McDade
    Michael Schöll
    Brian A. Gordon
    Randall J. Bateman
    Tammie L. S. Benzinger
    Nick C. Fox
    Alzheimer's Research & Therapy, 15
  • [47] Multicentric F-18-PI-2620 PET for in vivo Braak staging of tau pathology in Alzheimer's disease
    Rullmann, Michael
    Brendel, Matthias
    Schroeter, Matthias
    Saur, Dorothee
    Levin, Johannes
    Perneczky, Robert
    Tiepolt, Solveig
    Patt, Marianne
    Mueller, Andre
    Villemagne, Victor
    Classen, Joseph
    Stephens, Andrew
    Sabri, Osama
    Barthel, Henryk
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [48] Multicenter 18F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer's Disease
    Rullmann, Michael
    Brendel, Matthias
    Schroeter, Matthias L.
    Saur, Dorothee
    Levin, Johannes
    Perneczky, Robert G.
    Tiepolt, Solveig
    Patt, Marianne
    Mueller, Andre
    Villemagne, Victor L.
    Classen, Joseph
    Stephens, Andrew W.
    Sabri, Osama
    Barthel, Henryk
    BIOMOLECULES, 2022, 12 (03)
  • [49] Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease
    Harada, Ryuichi
    Ishiki, Aiko
    Kai, Hideaki
    Sato, Naomi
    Furukawa, Katsutoshi
    Furumoto, Shozo
    Tago, Tetsuro
    Tomita, Naoki
    Watanuki, Shoichi
    Hiraoka, Kotaro
    Ishikawa, Yoichi
    Funaki, Yoshihito
    Nakamura, Tadaho
    Yoshikawa, Takeo
    Iwata, Ren
    Tashiro, Manabu
    Sasano, Hironobu
    Kitamoto, Tetsuyuki
    Yanai, Kazuhiko
    Arai, Hiroyuki
    Kudo, Yukitsuka
    Okamura, Nobuyuki
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (04) : 671 - 674
  • [50] In vivo imaging of Tau deposition using a new tracer-18F-S16 in comparison with 18F-THK5317 in Alzheimer's disease
    Fu, L.
    Zhou, K.
    Zhang, X.
    Yi, F.
    Cui, M.
    Zhang, J.
    Xu, B.
    Tian, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S650 - S650